Dmitry Dobrovolskiy
Lawyers
Filters
PSG VI $6 billion fundraise and $2 billion continuation fund
We advised PSG on the fundraise for PSG VI and a multi-asset GP-led secondary continuation fund transaction
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S. listing
Sabre $800 million exchange offer and $775 million term loan exchange
We are advising Sabre on the exchange offers
Huntington Ingalls Industries $1 billion senior notes offering
The investment-grade notes are due 2030 and 2035
Atlantic Union Bankshares $402.5 million registered forward offering
We advised Atlantic Union Bankshares on the offering
Gran Tierra Energy $150 million notes offering
The 9.5% senior notes are due 2029
Voya Financial $400 million senior notes offering
The investment-grade notes are due 2034
Southwest Gas Holdings $340 million at-the-market offering
The shares are listed on the New York Stock Exchange
Zebra Technologies $500 million senior notes offering
The high-yield notes are due 2032
Cencosud $650 million senior notes offering
The senior notes are due 2031